Physician profile
Shruti B Benjamin
NPI 1578821815
$3,760.98
in general payments reported to CMS, 2019-2025
51 companies · $803 in 2025
The $803 reported for 2025 was more than what 82% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $104 · 2021: $531 · 2022: $891 · 2023: $615 · 2024: $658 · 2025: $803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,977 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,977.34 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $595.69 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Novo Nordisk INC | $302.45 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Astellas Pharma US INC | $252.83 | 2023-2025 | Veozah |
| Abbott Laboratories | $199.79 | 2021-2025 | Freestyle Libre 3, Proclaim |
| Mayne Pharma Commercial LLC | $179.78 | 2022-2025 | |
| Lilly USA, LLC | $169.47 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $154.67 | 2023-2025 | |
| Sage Therapeutics, LLC | $150.76 | 2024-2025 | Zurzuvae |
| Organon LLC | $123.00 | 2021-2025 | Nexplanon |
| Idorsia Pharmaceuticals US INC | $93.55 | 2022-2023 | Quviviq |
| Coopersurgical, INC. | $90.00 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $89.51 | 2021 | |
| Daiichi Sankyo INC. | $80.37 | 2020-2022 | |
| Aspira Women'S Health INC | $70.35 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $69.41 | 2022 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shruti Benjamin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.